It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In the revised diagnostic classification systems ICD-11 and DSM-5, secondary, organic forms of obsessive-compulsive disorder (OCD) are implemented as specific nosological entities. Therefore, the aim of this study was to clarify whether a comprehensive screening approach, such as the Freiburg-Diagnostic-Protocol for patients with OCD (FDP-OCD), is beneficial for detecting organic OCD forms. The FDP-OCD includes advanced laboratory tests, an expanded magnetic resonance imaging (MRI) protocol, and electroencephalography (EEG) investigations as well as automated MRI and EEG analyses. Cerebrospinal fluid (CSF), [18F]fluorodeoxyglucose positron emission tomography, and genetic analysis were added for patients with suspected organic OCD. The diagnostic findings of the first 61 consecutive OCD inpatients (32 female and 29 male; mean age: 32.7 ± 12.05 years) analyzed using our protocol were investigated. A probable organic cause was assumed in five patients (8%), which included three patients with autoimmune OCD (one patient with neurolupus and two with specific novel neuronal antibodies in CSF) and two patients with newly diagnosed genetic syndromes (both with matching MRI alterations). In another five patients (8%), possible organic OCD was detected (three autoimmune cases and two genetic cases). Immunological serum abnormalities were identified in the entire patient group, particularly with high rates of decreased “neurovitamin” levels (suboptimal vitamin D in 75% and folic acid in 21%) and increased streptococcal (in 46%) and antinuclear antibodies (ANAs; in 36%). In summary, the FDP-OCD screening led to the detection of probable or possible organic OCD forms in 16% of the patients with mostly autoimmune forms of OCD. The frequent presence of systemic autoantibodies such as ANAs further support the possible influence of autoimmune processes in subgroups of patients with OCD. Further research is needed to identify the prevalence of organic OCD forms and its treatment options.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
2 Medical Physics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Diagnostic and Interventional Radiology, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911); Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Stereotactic and Functional Neurosurgery, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
3 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Neuroradiology, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
4 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Rheumatology and Clinical Immunology, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
5 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Institute of Human Genetics, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
6 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Laboratory of Clinical Biochemistry and Metabolism, Department of General Pediatrics, Adolescent Medicine and Neonatology, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)
7 Charité - Universitätsmedizin Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)
8 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911); Center for Basics in Neuromodulation, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany (GRID:grid.7708.8) (ISNI:0000 0000 9428 7911)